Stratos Genomics Receives Fundamental Patent on Sequencing by Expansion™ Technology
SEATTLE, WA--(Marketwire - May 25, 2011) - Stratos Genomics Inc today announced it has been granted US Patent 7,939,259 titled "High Throughput Nucleic Acid Sequencing by Expansion." Sequencing by Expansion™ (SBX™) is a method for converting DNA into a more easily-read polymer called an Xpandomer™. Xpandomers encode DNA base sequence information with high signal-to-noise reporters optimally positioned along the polymer chain. SBX is a solution to the intrinsic problem of sequencing native DNA at high-speed and low cost.
The limited signal differentiation of DNA molecules is the overriding factor driving the economics of sequencing today. Existing sequencing technologies overcome the signal-to-noise limitation through intensive sample preparation, complex processing and expensive instrumentation. In contrast, SBX's high signal-to-noise Xpandomers prepared by simple solution-based processing enable ultra-low-cost, single-molecule sequencing on a range of affordable measurement technologies for servicing a full spectrum of genomic applications, including personalized medicine, pathogen identification and environmental monitoring.
Visit the US Patent website for full text of the patent.
About Stratos Genomics Inc
Stratos Genomics' goal is to establish the next gold standard of DNA sequencing with its flagship "Sequencing by Expansion™" (SBX™) method. SBX is a simple, elegant, single-molecule detection process that circumvents the limitations of competing technologies, allowing accurate, ultra-low-cost whole genome sequencing.
Established in 2007, Stratos Genomics Inc is a spin-off of Seattle-based Stratos Group LLC. The company is composed of an accomplished team of scientists, engineers, advisors and directors. It was founded by Stratos Group and Stratos Genomics' officers: CEO Allan Stephan, CSO Mark Kokoris and CTO Bob McRuer, Ph.D. Stratos Genomics' board of directors includes Stephan, Kokoris, McRuer, Harold Kawaguchi (Chairman- Stratos Group), Lee Huntsman, Ph.D (President Emeritus- University of Washington), Heiner Dreismann, Ph.D (Retired CEO- Roche Molecular Diagnostics) and Stephen Rose (Managing Director- Fisk Ventures). Stratos Genomics' science advisory board includes Lawrence Loeb, M.D./ Ph.D; Robert Franza, M.D.; Andre Marziali, Ph.D; Eugene Kolker, Ph.D; Patrick Stayton, Ph.D; Jay Shendure, Ph.D and Buddy Ratner, Ph.D.
About Stratos Group LLC
Stratos Group is dedicated to the conversion of science and technology into commercial solutions for the advancement of mankind and the protection of the environment. Also under the Stratos Group umbrella is Stratos Product Development, LLC. Stratos Product Development is a world leader in high tech product development services.
Director, Marketing Communications